According to ALX Oncology's latest financial reports the company's current earnings (TTM) are -A$0.26 B. In 2023 the company made an earning of -A$0.24 B a decrease over its 2022 earnings that were of -A$0.19 B.The earnings displayed on this page is the company's Pretax Income.